✦ LIBER ✦

PMH45 MEASURES OF MEDICATION ADHERENCE IN ORAL VERSUS LONG-ACTING RISPERIDONE IN TEXAS MEDICAID PATIENTS WITH SCHIZOPHRENIA

✍ Scribed by Kim, D.N.; Park, H.; Rascati, K.L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH31 Cost-Effectiveness of Long-Acting

✍ T. Dilla; P. O'Donohoe; J. Möller; M. Álvarez; J. Sacristán; L. San; M. Happich; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMH22 HOSPITALIZATION AND MEDICATION USE

✍ P Chue; A Lam; K Chandra; D Luong; F Camacho 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PMH24 Cost of Long-Acting Risperidone In

✍ V. Omelyanovsky; M. Avxentyeva; O. Ivakhnenko; P. Khailov; F.M. Tsfasman; I. Kry 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMH23 IMPACT OF RISPERIDONE LONG-ACTING

✍ L Beauclair; A Lam; J McCormick; D Luong; F Camacho 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PMH42 IMPACT OF RISPERIDONE LONG-ACTING

✍ JM Olivares; A Rodriguez-Morales; JK Diels; M Povey; A Lam; A Jacobs; Z Zhao 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

PMH35 COMPARISONS OF MENTAL HEALTH-RELAT

✍ Park, H.; Kim, D.N.; Rascati, K.L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB